tiprankstipranks
Trending News
More News >
TherapeuticsMD (TXMD)
NASDAQ:TXMD
US Market

TherapeuticsMD (TXMD) Income Statement

Compare
2,246 Followers

TherapeuticsMD Income Statement

Last quarter (Q3 2025), TherapeuticsMD's total revenue was $784.00K, an increase of 43.33% from the same quarter last year. In Q3, TherapeuticsMD's net income was $152.00K. See TherapeuticsMD’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.76M$ 1.30M$ 69.96M$ 2.57M$ 64.87M
Gross Profit
$ 1.76M$ 1.30M$ 68.57M$ 1.17M$ 48.90M
Operating Expenses
$ 6.52M$ 9.82M$ 67.38M$ 80.75M$ 204.44M
Depreciation and Amortization
$ 509.00K$ 438.50K$ 1.20M$ 736.00K$ 4.07M
EBITDA
$ -2.98M$ -8.08M$ 11.86M$ -70.84M$ -153.41M
Operating Income
$ -4.76M$ -8.52M$ 1.19M$ -79.58M$ -155.54M
Other Income/Expenses
$ 2.42M$ 781.00K$ -117.00K$ 272.00K$ -27.98M
Pretax Income
$ -2.34M$ -7.74M$ 1.07M$ -79.31M$ -183.52M
Net Income
$ -2.18M$ -10.28M$ 112.00M$ -172.41M$ -183.52M
Per Share Metrics
Basic EPS
$ -0.19$ -0.55$ -10.35$ -25.83$ -38.58
Diluted EPS
$ -0.19$ -0.74$ -10.35$ -25.83$ -38.58
Weighted Average Shares Outstanding
11.53M 10.44M 9.03M 7.96M 5.51M
Weighted Average Shares Outstanding (Diluted)
11.53M 10.44M 9.03M 7.96M 5.51M
Currency in USD

TherapeuticsMD Earnings and Revenue History